
Jean F. Voltaire
Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )
| Most Active Art Unit | 2466 |
| Art Unit(s) | 2466, 2417 |
| Total Applications | 487 |
| Issued Applications | 381 |
| Pending Applications | 55 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12246232
[patent_doc_number] => 09918995
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-20
[patent_title] => 'Ciclesonide for the treatment of airway disease in horses'
[patent_app_type] => utility
[patent_app_number] => 14/654009
[patent_app_country] => US
[patent_app_date] => 2013-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 10387
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14654009
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/654009 | Ciclesonide for the treatment of airway disease in horses | Dec 17, 2013 | Issued |
Array
(
[id] => 10457874
[patent_doc_number] => 20150342889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'TABLETS WITH IMPROVED ACCEPTANCE AND GOOD STORAGE STABILITY'
[patent_app_type] => utility
[patent_app_number] => 14/653676
[patent_app_country] => US
[patent_app_date] => 2013-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3985
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14653676
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/653676 | Tablets with improved acceptance and good storage stability | Dec 16, 2013 | Issued |
Array
(
[id] => 13645685
[patent_doc_number] => 09849141
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-26
[patent_title] => Use of spironolactone-based composition that exhibits an inhibitory action on T-lymphocyte activation which is useful for preventing and/or treating multiple sclerosis
[patent_app_type] => utility
[patent_app_number] => 14/104799
[patent_app_country] => US
[patent_app_date] => 2013-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4589
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14104799
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/104799 | Use of spironolactone-based composition that exhibits an inhibitory action on T-lymphocyte activation which is useful for preventing and/or treating multiple sclerosis | Dec 11, 2013 | Issued |
Array
(
[id] => 10457207
[patent_doc_number] => 20150342222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'NOVEL USE OF CANTHAXANTHIN AND 25-HYDROXY VITAMIN D3'
[patent_app_type] => utility
[patent_app_number] => 14/655115
[patent_app_country] => US
[patent_app_date] => 2013-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1893
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14655115
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/655115 | NOVEL USE OF CANTHAXANTHIN AND 25-HYDROXY VITAMIN D3 | Dec 11, 2013 | Abandoned |
Array
(
[id] => 9371016
[patent_doc_number] => 20140080889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'Statin and Omega-3 Fatty Acids for Lipid Therapy'
[patent_app_type] => utility
[patent_app_number] => 14/088621
[patent_app_country] => US
[patent_app_date] => 2013-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8909
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14088621
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/088621 | Statin and Omega-3 Fatty Acids for Lipid Therapy | Nov 24, 2013 | Abandoned |
Array
(
[id] => 11217719
[patent_doc_number] => 09446038
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-20
[patent_title] => 'Method and composition for treating a serotonin receptor-mediated condition'
[patent_app_type] => utility
[patent_app_number] => 14/088877
[patent_app_country] => US
[patent_app_date] => 2013-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4681
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14088877
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/088877 | Method and composition for treating a serotonin receptor-mediated condition | Nov 24, 2013 | Issued |
Array
(
[id] => 9369939
[patent_doc_number] => 20140079812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'Disulfide Chemotherapeutic Agents and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/084064
[patent_app_country] => US
[patent_app_date] => 2013-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 6332
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14084064
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/084064 | Disulfide chemotherapeutic agents and methods of use thereof | Nov 18, 2013 | Issued |
Array
(
[id] => 10437020
[patent_doc_number] => 20150322033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'ANTIBACTERIAL AGENT'
[patent_app_type] => utility
[patent_app_number] => 14/441973
[patent_app_country] => US
[patent_app_date] => 2013-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16547
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14441973
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/441973 | ANTIBACTERIAL AGENT | Nov 11, 2013 | Abandoned |
Array
(
[id] => 13222665
[patent_doc_number] => 10125097
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-13
[patent_title] => 1- [1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives
[patent_app_type] => utility
[patent_app_number] => 14/436715
[patent_app_country] => US
[patent_app_date] => 2013-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 15257
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436715
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/436715 | 1- [1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives | Nov 10, 2013 | Issued |
Array
(
[id] => 9338461
[patent_doc_number] => 20140065243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/075848
[patent_app_country] => US
[patent_app_date] => 2013-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15450
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075848
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/075848 | Methods and compositions for treating cancer | Nov 7, 2013 | Issued |
Array
(
[id] => 9331116
[patent_doc_number] => 20140057898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 14/071166
[patent_app_country] => US
[patent_app_date] => 2013-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17849
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14071166
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/071166 | COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS | Nov 3, 2013 | Abandoned |
Array
(
[id] => 9450065
[patent_doc_number] => 20140121235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'Method for Treating S6K-Overexpressing Cancers'
[patent_app_type] => utility
[patent_app_number] => 14/063877
[patent_app_country] => US
[patent_app_date] => 2013-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 11664
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14063877
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/063877 | Method for Treating S6K-Overexpressing Cancers | Oct 24, 2013 | Abandoned |
Array
(
[id] => 9307264
[patent_doc_number] => 20140045938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'Substituted Phenyl Aziridine Precursor Analogs for Inhibiting Androgen-Independent Prostate Cancer Cell Growth'
[patent_app_type] => utility
[patent_app_number] => 14/057518
[patent_app_country] => US
[patent_app_date] => 2013-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11823
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14057518
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/057518 | Substituted Phenyl Aziridine Precursor Analogs for Inhibiting Androgen-Independent Prostate Cancer Cell Growth | Oct 17, 2013 | Abandoned |
Array
(
[id] => 10974272
[patent_doc_number] => 20140377307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'USE OF INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE IN COMBINATION WITH OTHER THERAPEUTIC MODALITIES'
[patent_app_type] => utility
[patent_app_number] => 14/048757
[patent_app_country] => US
[patent_app_date] => 2013-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 20467
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14048757
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/048757 | Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities | Oct 7, 2013 | Issued |
Array
(
[id] => 10331829
[patent_doc_number] => 20150216833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'Therapeutic for Treating Inflammatory Lung Disorders'
[patent_app_type] => utility
[patent_app_number] => 14/431382
[patent_app_country] => US
[patent_app_date] => 2013-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10800
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14431382
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/431382 | Therapeutic for treating inflammatory lung disorders | Sep 24, 2013 | Issued |
Array
(
[id] => 10331829
[patent_doc_number] => 20150216833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'Therapeutic for Treating Inflammatory Lung Disorders'
[patent_app_type] => utility
[patent_app_number] => 14/431382
[patent_app_country] => US
[patent_app_date] => 2013-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10800
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14431382
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/431382 | Therapeutic for treating inflammatory lung disorders | Sep 24, 2013 | Issued |
Array
(
[id] => 10360608
[patent_doc_number] => 20150245613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'PLANT DISEASE CONTROLLING AGENT, PLANT DISEASE CONTROLLING METHOD, AND PLANT DISEASE CONTROLLING PRODUCT'
[patent_app_type] => utility
[patent_app_number] => 14/417892
[patent_app_country] => US
[patent_app_date] => 2013-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5464
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14417892
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/417892 | PLANT DISEASE CONTROLLING AGENT, PLANT DISEASE CONTROLLING METHOD, AND PLANT DISEASE CONTROLLING PRODUCT | Sep 11, 2013 | Abandoned |
Array
(
[id] => 10353434
[patent_doc_number] => 20150238439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING DNMT1 INHIBITOR ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/426399
[patent_app_country] => US
[patent_app_date] => 2013-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 14841
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14426399
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/426399 | Compositions and methods for modulating DNMT1 inhibitor activity | Sep 5, 2013 | Issued |
Array
(
[id] => 9262209
[patent_doc_number] => 20130344138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'METHODS OF TREATMENT FOR SOLID TUMORS'
[patent_app_type] => utility
[patent_app_number] => 14/012929
[patent_app_country] => US
[patent_app_date] => 2013-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12292
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14012929
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/012929 | METHODS OF TREATMENT FOR SOLID TUMORS | Aug 27, 2013 | Abandoned |
Array
(
[id] => 9295412
[patent_doc_number] => 20140039046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'COMPOSITIONS AND PRODUCTS CONTAINING S-EQUOL, AND METHODS FOR THEIR MAKING'
[patent_app_type] => utility
[patent_app_number] => 14/012630
[patent_app_country] => US
[patent_app_date] => 2013-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15105
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14012630
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/012630 | COMPOSITIONS AND PRODUCTS CONTAINING S-EQUOL, AND METHODS FOR THEIR MAKING | Aug 27, 2013 | Abandoned |